21695-099 NDC - ORPHENADRINE CITRATE ()

Drug Information

Product NDC: 21695-099

Proprietary Name: Orphenadrine Citrate

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Rebel Distributors Corp
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:6/19/1998

Package Information

No. Package Code Package Description Billing Unit
121695-099-1414 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-099-14)EA
221695-099-2020 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-099-20)EA
321695-099-2828 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-099-28)EA
421695-099-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-099-30)EA
521695-099-5656 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-099-56)EA
621695-099-6060 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-099-60)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC21695-099The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEOrphenadrine CitrateThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE6/19/1998This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMERebel Distributors CorpName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023